Correlation Between Migdal Insurance and Medivie Therapeutic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Migdal Insurance and Medivie Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Migdal Insurance and Medivie Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Migdal Insurance and Medivie Therapeutic, you can compare the effects of market volatilities on Migdal Insurance and Medivie Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Migdal Insurance with a short position of Medivie Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Migdal Insurance and Medivie Therapeutic.

Diversification Opportunities for Migdal Insurance and Medivie Therapeutic

-0.86
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Migdal and Medivie is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Migdal Insurance and Medivie Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medivie Therapeutic and Migdal Insurance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Migdal Insurance are associated (or correlated) with Medivie Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medivie Therapeutic has no effect on the direction of Migdal Insurance i.e., Migdal Insurance and Medivie Therapeutic go up and down completely randomly.

Pair Corralation between Migdal Insurance and Medivie Therapeutic

Assuming the 90 days trading horizon Migdal Insurance is expected to generate 0.27 times more return on investment than Medivie Therapeutic. However, Migdal Insurance is 3.65 times less risky than Medivie Therapeutic. It trades about 0.22 of its potential returns per unit of risk. Medivie Therapeutic is currently generating about -0.29 per unit of risk. If you would invest  60,900  in Migdal Insurance on September 1, 2024 and sell it today you would earn a total of  3,790  from holding Migdal Insurance or generate 6.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Migdal Insurance  vs.  Medivie Therapeutic

 Performance 
       Timeline  
Migdal Insurance 

Risk-Adjusted Performance

34 of 100

 
Weak
 
Strong
Very Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Migdal Insurance are ranked lower than 34 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Migdal Insurance sustained solid returns over the last few months and may actually be approaching a breakup point.
Medivie Therapeutic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medivie Therapeutic has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Migdal Insurance and Medivie Therapeutic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Migdal Insurance and Medivie Therapeutic

The main advantage of trading using opposite Migdal Insurance and Medivie Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Migdal Insurance position performs unexpectedly, Medivie Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medivie Therapeutic will offset losses from the drop in Medivie Therapeutic's long position.
The idea behind Migdal Insurance and Medivie Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals